Despite Trump's return to office and compressed global valuations, China's innovative healthcare market presents strategic potential for foreign investors willing to navigate regulatory complexities and sector-specific challenges.
In an interview on the back of the launch of Nuveen’s 2022 EQuilibirum survey of global institutional investors, Nick Liolis, the chief investment officer at TIAA and Amy O’Brien, the global head of responsible investing at Nuveen speak about how insurance companies approach impact investing.